148 related articles for article (PubMed ID: 16740029)
1. Beta-catenin nuclear expression correlates with cyclin D1 expression in primary and metastatic synovial sarcoma: a tissue microarray study.
Horvai AE; Kramer MJ; O'Donnell R
Arch Pathol Lab Med; 2006 Jun; 130(6):792-8. PubMed ID: 16740029
[TBL] [Abstract][Full Text] [Related]
2. Nuclear beta-catenin correlates with cyclin D1 expression in spindle and pleomorphic sarcomas but not in synovial sarcoma.
Saito T; Oda Y; Yamamoto H; Kawaguchi K; Tanaka K; Matsuda S; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2006 Jun; 37(6):689-97. PubMed ID: 16733209
[TBL] [Abstract][Full Text] [Related]
3. Primary intrathoracic synovial sarcoma: a clinicopathologic study of 40 t(X;18)-positive cases from the French Sarcoma Group and the Mesopath Group.
Bégueret H; Galateau-Salle F; Guillou L; Chetaille B; Brambilla E; Vignaud JM; Terrier P; Groussard O; Coindre JM
Am J Surg Pathol; 2005 Mar; 29(3):339-46. PubMed ID: 15725802
[TBL] [Abstract][Full Text] [Related]
4. SYT-SSX is critical for cyclin D1 expression in synovial sarcoma cells: a gain of function of the t(X;18)(p11.2;q11.2) translocation.
Xie Y; Skytting B; Nilsson G; Gasbarri A; Haslam K; Bartolazzi A; Brodin B; Mandahl N; Larsson O
Cancer Res; 2002 Jul; 62(13):3861-7. PubMed ID: 12097301
[TBL] [Abstract][Full Text] [Related]
5. Monophasic fibrous and poorly differentiated synovial sarcoma: immunohistochemical reassessment of 60 t(X;18)(SYT-SSX)-positive cases.
Pelmus M; Guillou L; Hostein I; Sierankowski G; Lussan C; Coindre JM
Am J Surg Pathol; 2002 Nov; 26(11):1434-40. PubMed ID: 12409719
[TBL] [Abstract][Full Text] [Related]
6. Targeting Cyclin-Dependent Kinases in Synovial Sarcoma: Palbociclib as a Potential Treatment for Synovial Sarcoma Patients.
Vlenterie M; Hillebrandt-Roeffen MH; Schaars EW; Flucke UE; Fleuren ED; Navis AC; Leenders WP; Versleijen-Jonkers YM; van der Graaf WT
Ann Surg Oncol; 2016 Sep; 23(9):2745-52. PubMed ID: 27334220
[TBL] [Abstract][Full Text] [Related]
7. The synovial sarcoma translocation protein SYT-SSX2 recruits beta-catenin to the nucleus and associates with it in an active complex.
Pretto D; Barco R; Rivera J; Neel N; Gustavson MD; Eid JE
Oncogene; 2006 Jun; 25(26):3661-9. PubMed ID: 16462762
[TBL] [Abstract][Full Text] [Related]
8. Molecular and immunohistochemical analyses of BCL2, KI-67, and cyclin D1 expression in synovial sarcoma.
Krsková L; Kalinová M; Brízová H; Mrhalová M; Sumerauer D; Kodet R
Cancer Genet Cytogenet; 2009 Aug; 193(1):1-8. PubMed ID: 19602458
[TBL] [Abstract][Full Text] [Related]
9. Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma.
Antonescu CR; Kawai A; Leung DH; Lonardo F; Woodruff JM; Healey JH; Ladanyi M
Diagn Mol Pathol; 2000 Mar; 9(1):1-8. PubMed ID: 10718206
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence in situ hybridization for the detection of t(X;18)(p11.2;q11.2) in a synovial sarcoma tissue microarray using a breakapart-style probe.
Terry J; Barry TS; Horsman DE; Hsu FD; Gown AM; Huntsman DG; Nielsen TO
Diagn Mol Pathol; 2005 Jun; 14(2):77-82. PubMed ID: 15905690
[TBL] [Abstract][Full Text] [Related]
11. SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma.
Trautmann M; Sievers E; Aretz S; Kindler D; Michels S; Friedrichs N; Renner M; Kirfel J; Steiner S; Huss S; Koch A; Penzel R; Larsson O; Kawai A; Tanaka S; Sonobe H; Waha A; Schirmacher P; Mechtersheimer G; Wardelmann E; Büttner R; Hartmann W
Oncogene; 2014 Oct; 33(42):5006-16. PubMed ID: 24166495
[TBL] [Abstract][Full Text] [Related]
12. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M
Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
[TBL] [Abstract][Full Text] [Related]
13. p16INK4A (CDKN2A) gene deletion is a frequent genetic event in synovial sarcomas.
Subramaniam MM; Noguera R; Piqueras M; Navarro S; López-Guerrero JA; Llombart-Bosch A
Am J Clin Pathol; 2006 Dec; 126(6):866-74. PubMed ID: 17074682
[TBL] [Abstract][Full Text] [Related]
14. Alterations of cell cycle regulators in localized synovial sarcoma: A multifactorial study with prognostic implications.
Antonescu CR; Leung DH; Dudas M; Ladanyi M; Brennan M; Woodruff JM; Cordon-Cardo C
Am J Pathol; 2000 Mar; 156(3):977-83. PubMed ID: 10702413
[TBL] [Abstract][Full Text] [Related]
15. Coincident expression of beta-catenin and cyclin D1 in endometrial stromal tumors and related high-grade sarcomas.
Kurihara S; Oda Y; Ohishi Y; Kaneki E; Kobayashi H; Wake N; Tsuneyoshi M
Mod Pathol; 2010 Feb; 23(2):225-34. PubMed ID: 19898427
[TBL] [Abstract][Full Text] [Related]
16. Detection of the synovial sarcoma translocation t(X;18) (SYT;SSX) in paraffin-embedded tissues using reverse transcriptase-polymerase chain reaction: a reliable and powerful diagnostic tool for pathologists. A molecular analysis of 221 mesenchymal tumors fixed in different fixatives.
Guillou L; Coindre J; Gallagher G; Terrier P; Gebhard S; de Saint Aubain Somerhausen N; Michels J; Jundt G; Vince DR; Collin F; Trassard M; Le Doussal V; Benhattar J
Hum Pathol; 2001 Jan; 32(1):105-12. PubMed ID: 11172303
[TBL] [Abstract][Full Text] [Related]
17. The Wnt/β-catenin pathway drives increased cyclin D1 levels in lymph node metastasis in papillary thyroid cancer.
Zhang J; Gill AJ; Issacs JD; Atmore B; Johns A; Delbridge LW; Lai R; McMullen TP
Hum Pathol; 2012 Jul; 43(7):1044-50. PubMed ID: 22204713
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of cyclin D1, β-catenin, and MTA1 in patients with invasive ductal carcinoma of the breast.
Cheng CW; Liu YF; Yu JC; Wang HW; Ding SL; Hsiung CN; Hsu HM; Shieh JC; Wu PE; Shen CY
Ann Surg Oncol; 2012 Dec; 19(13):4129-39. PubMed ID: 22864797
[TBL] [Abstract][Full Text] [Related]
19. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin.
Wang HL; Wang J; Xiao SY; Haydon R; Stoiber D; He TC; Bissonnette M; Hart J
Int J Cancer; 2002 Oct; 101(4):301-10. PubMed ID: 12209953
[TBL] [Abstract][Full Text] [Related]
20. Pleuropulmonary desmoid tumors: immunohistochemical comparison with solitary fibrous tumors and assessment of beta-catenin and cyclin D1 expression.
Andino L; Cagle PT; Murer B; Lu L; Popper HH; Galateau-Salle F; Sienko AE; Barrios R; Zander DS
Arch Pathol Lab Med; 2006 Oct; 130(10):1503-9. PubMed ID: 17090192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
